Stocks
Novo Nordisk (NVO) OCF US GAAP (year values) |
|||||||||
| 2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| OCF | ? | 55 000 000 000 | 55 000 000 000 | 78 887 000 000 | 78 887 000 000 | 108 908 000 000 | 115 334 000 000 | ||
| Changes by years, y/y, % | +6% | 0% | +43% | 0% | +38% | +19.5% | |||
Novo Nordisk. OCF
Novo Nordisk. OCF, changes, %
Novo Nordisk. OCF, sum by quarters
Novo Nordisk (NVO) OCF US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| OCF | ? | 28 577 000 000 | 40 966 000 000 | 9 551 000 000 | 14 314 000 000 | 50 503 000 000 | 115 334 000 000 | |
| Changes by years, y/y, % | +19% | +69% | +35% | -52% | +77% | |||
| Changes by quarters, q/q, % | +43% | -77% | +50% | +253% | ||||
